Company Focus

Novo Nordisk

Latest Novo Nordisk News

Novo files for EMA approval of higher-dose Wegovy as Indian market heats up
Pharmaceutical
Danish drugmaker Novo Nordisk has filed for European approval of a higher-dose version of its obesity treatment Wegovy (semaglutide), aiming to expand options for patients who need stronger support for weight loss.   9 July 2025


Insights

Company Spotlight

Latest News & Features of interest to Novo Nordisk

Latest In Brief for Novo Nordisk

Pharmaceutical
Ireland-based biopharma Jazz Pharmaceuticals has been called out for a couple of indiscretions by The Prescription Medicines Code of Practice Authority (PMCPA), which was established by the Association of the British Pharmaceutical Industry (ABPI) to operate the ABPI Code of Practice for the Pharmaceutical Industry.   11 July 2025

Latest Related Ones To Watch News

US pharma major AbbVie announced it plan to acquire Capstan Therapeutics, along with its autoimmune disease candidate CPTX2309, for up to $2.1 billion. Organon posted disappointing mid-stage trial results for its investigational endometriosis pain drug, OG-6219. Also of note last week, the US Food and drug Administration (FDA) granted accelerated approval for Regeneron’s multiple myeloma drug Lynozyfic.   6 July 2025

More in M&A >


Related Ones to Watch Companies

Reset all filters
Refine Search